Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma
Status:
Completed
Trial end date:
2000-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Hyperthermia therapy kills tumor cells by heating them to several
degrees above body temperature. Combining hyperthermia with chemotherapy may kill more tumor
cells.
PURPOSE: Phase II trial to study the effectiveness of melphalan and whole-body hyperthermia
in treating patients with advanced melanoma.